PARP inhibitor augments anti-tumor efficacy of DNMT inhibitor by inducing senescence in cholangiocarcinomaPeili Wang(Sun Yat-sen University), Jing Tan(Sun Yat-sen University)International Journal of Biological SciencesMay 27, 202510.7150/ijbs.110947Cited by 6SaveCiteExport RISWatch citationsRelated PapersSREBP1 induction mediates long-term statins therapy related myocardial lipid peroxidation and lipid deposition in TIIDM mice|Redox Biology|2024|10Sustained SREBP-1 Activation Mediates Cardiac Lipotoxicity to Statins Therapy in Diabetic Mice|Research Square|2023|0